ArticleClinical case reports2026

Paradoxical Efficacy With Rare Adverse Events: Sequential ALK Inhibitor Therapy in Lung Adenocarcinoma.

Kang Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.